A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.
This genomic diagnostics company saw a notable insider sale, as shares have surged over 70% in the past year.
Overview
Jonathan Wygant, Vice President and Chief Accounting Officer of Veracyte (NASDAQ:VCYT), reported the exercise of 24,000 options and immediate open-market sale of the same number of shares for a total transaction value of approximately $1.09 million, according to the SEC Form 4 filing dated May 27, 2026.
Transaction value based on SEC Form 4 weighted average reported price ($45.40); post-transaction value based on May 22, 2026 market close.
Details
* 1-year performance calculated using May 22, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.